78 related articles for article (PubMed ID: 8992673)
1. [Purine analogs in chronic lymphatic leukemia].
Ellegaard J
Ugeskr Laeger; 1996 Nov; 158(45):6413. PubMed ID: 8992673
[No Abstract] [Full Text] [Related]
2. Management of advanced chronic lymphocytic leukemia.
Cao TM; Coutre SE
Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
[TBL] [Abstract][Full Text] [Related]
3. [Purine analogs of the second generation in treatment of chronic lymphocytic leukemia].
Rupniewska ZM; Dmoszyńska A; Roliński J
Pol Arch Med Wewn; 1994 Apr; 91(4):302-10. PubMed ID: 8072892
[No Abstract] [Full Text] [Related]
4. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
5. Novel therapies for chronic lymphocytic leukemia in the 21st century.
Byrd JC; Waselenko JK; Keating M; Rai K; Grever MR
Semin Oncol; 2000 Oct; 27(5):587-97. PubMed ID: 11049025
[TBL] [Abstract][Full Text] [Related]
6. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
Kay NE
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on purine analogues.
Cheson BD
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
[TBL] [Abstract][Full Text] [Related]
8. Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia.
Dillman RO
Expert Rev Anticancer Ther; 2004 Feb; 4(1):27-36. PubMed ID: 14748654
[TBL] [Abstract][Full Text] [Related]
9. Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia.
Orioli L; Sarti K; Van Den Neste E; Maiter D
Ann Hematol; 2017 Apr; 96(4):685-686. PubMed ID: 28150013
[No Abstract] [Full Text] [Related]
10. Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia.
Lamanna N; Weiss MA
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S44-9. PubMed ID: 16549114
[TBL] [Abstract][Full Text] [Related]
11. Promising results Halt phase III studies of idelalisib.
Inman S
Am J Manag Care; 2014 Feb; 20(2 Spec No.):E9. PubMed ID: 25764575
[No Abstract] [Full Text] [Related]
12. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492
[TBL] [Abstract][Full Text] [Related]
13. The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapy.
Giné E; Moreno C; Esteve J; Montserrat E
Best Pract Res Clin Haematol; 2007 Sep; 20(3):529-43. PubMed ID: 17707838
[TBL] [Abstract][Full Text] [Related]
14. [Chronic lymphatic leukemia. Peroral cladribine as primary treatment].
Gjedde SB; Juliusson G; Hansen MM
Ugeskr Laeger; 1996 Nov; 158(45):6432-4. PubMed ID: 8992677
[TBL] [Abstract][Full Text] [Related]
15. Purine analogs in leukemia.
Lamanna N; Weiss M
Adv Pharmacol; 2004; 51():107-25. PubMed ID: 15464907
[No Abstract] [Full Text] [Related]
16. [Chronic lymphatic leukemia: significance of erythropoietin].
Barthel HR
Dtsch Med Wochenschr; 2002 May; 127(18):982; author reply 982-3. PubMed ID: 11987022
[No Abstract] [Full Text] [Related]
17. Infectious complications of chronic lymphocytic leukemia.
Wadhwa PD; Morrison VA
Semin Oncol; 2006 Apr; 33(2):240-9. PubMed ID: 16616071
[TBL] [Abstract][Full Text] [Related]
18. Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia.
Rogalinska M; Goralski P; Wozniak K; Bednarek JD; Blonski JZ; Robak T; Piekarski H; Hanausek M; Walaszek Z; Kilianska ZM
Leuk Res; 2009 Feb; 33(2):308-14. PubMed ID: 18676014
[TBL] [Abstract][Full Text] [Related]
19. Hairy cell leukemia: treatment prospects.
Seshadri P; Seshadri R
Expert Rev Anticancer Ther; 2001 Jun; 1(1):91-8. PubMed ID: 12113139
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
Lam CC; Ma ES; Kwong YL
Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
